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For personalBackground/Purpose: Tuberculosis (TB) is a crucial health problem. Prevention of the disease
requires rapid diagnosis. Rapid liquid culture systems, nucleic acid amplification tests, and
high-performance liquid chromatography (HPLC) are among the rapid tests used for detecting
Mycobacterium species. However, these tests are expensive and require extensive equipment
and expertise, which is hardly affordable in resource-poor countries. Although direct micro-
scopy is performed routinely as an initial step for detection of the bacteria, it is not sufficiently
sensitive. As a result, we thought of establishing a low-cost immunological test that can poten-
tially replace direct microscopy with higher sensitivity and specificity.
Methods: The assay is based on pre-incubation of biotinylated rabbit antibody against Antigen
60 (A60) with a solution containing Bacillus Calmette-Gue´rin (BCG) or Mycobacterium tubercu-
losis (MTB) followed by incubation with a streptavidinealkaline phosphatase (STAeALP) conju-
gate. The test is devised in enzyme-linked immunosorbent assay (ELISA) and non-ELISA
formats, therefore it does not require extensive facilities and expertise.
Results: The ELISA format showed a 100-fold improvement in the lower detection limit of BCG
compared with direct microscopy. With the non-ELISA formats, there was a 2- and 16-fold
improvement for the cartridge assay and the microfuge tube assay, respectively.
Conclusion: In conclusion, we successfully detected BCG and MTB in solution using the new
immunological method. Our results are very promising and the new immunological method
could potentially replace direct microscopy with higher sensitivity and specificity.
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Tuberculosis (TB) is a crucial health problem worldwide,
based on a report from the World Health Organization
(WHO), with 8.7 million cases in 2011.1 To prevent further
transmission and prompt treatment, Mycobacterium
tuberculosis (MTB) species must be identified rapidly and
specifically. New tests including nucleic acid amplification
tests for rapid diagnostics of TB infection have been
established.2 Nevertheless, due to the considerable cost of
laboratory equipment and the skills required to perform
these tests, these methods have been rarely used in third-
world countries where TB has the highest prevalence.
Among the rapid diagnostic tests for the detection of pul-
monary TB, direct microscopy of acid-fast bacteria (AFB)
using the Ziehl-Neelsen (ZN) staining method remains the
most rapid and low-cost technique and often the best op-
tion in developing countries.2 However, only 40e50% of
patients with pulmonary TB are smear-positive3 and ironi-
cally about 17% of TB transmission is through patients with
smear-negative and culture-positive TB.4 By contrast, the
Centers for Disease Control (CDC) recommends that 3
consecutive days of sputum collection is needed for initial
diagnosis of TB; in developing countries, due to the high
workload, laboratory technicians have to prepare a large
number of slides every day resulting in a lower quality
diagnostic service.5 The challenge is to develop a simple
and inexpensive test with more sensitivity and specificity
than that of direct microscopy that could be widely used in
resource-poor countries.
In this study, we have developed an assay that could be
a potential candidate to replace direct microscopy for
detecting various TB species with high sensitivity and
specificity. The assay is based on detection of Bacillus
Calmette-Gue´rin (BCG) or MTB using a specific bio-
tinylated rabbit polyclonal antibody against Antigen 60
(A60) and a streptavidinealkaline phosphatase (STAeALP)
conjugate.
The sensitivity of detecting antibodies against MTB A60 in
patientswith active pulmonary TB is very high, as reported in
many published studies.6e9 Our results are very promising,
and the assay may be applicable to detect a wide variety of
MTB species in sputum and other body fluids.
Methods
Reagents and materials
BCG was purchased as a BCG vaccine from the Pasteur
Institute of Iran (Tehran, Iran). Polyclonal rabbit antibody
against A60 and the test cartridges were gifts from Anda
Biologicals Company (Strasbourg, France). Antibody bio-
tinylation was performed using Immunoprobe Bio-
tinylation Kit (catalog no. BK-101) purchased from Sigma-
Aldrich (St. Louis, MO, USA). p-Nitrophenyl Phosphate
(pNPP) and Avidin was purchased from Pierce (Rockford,
IL, USA) and Tween-20 from Bio-Rad Laboratories (Her-
cules, CA, USA). Diethanolamine (DEA), bovine serum al-
bumin (BSA), STAeALP, and dimethyl sulfoxide (DMSO)
were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Nunc-Immuno MicroWell was purchased from Sigma-Downloaded for Anonymous User (n/a) at Iran University of Medical 
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column was purchased from Amersham Biosciences
(Uppsala, Sweden).
ZN staining
Different concentrations of BCG preserved in phosphate-
buffered saline (PBS) were stained using the ZN staining
method. According to the following reporting scale: ZNe,
no AFB per 300 fields; ZN, 1e9 AFB per 100 fields; ZN1þ,
10e99 AFB per 100 fields; ZN2þ, 1e10 AFB per field in at
least 50 fields; and ZN3þ, >10 AFB per field in at least 20
fields.
Antibody purification
The antibody against A60 was desalted by a gel filtration
step using a Sephadex G-25 column.
Antibody biotinylation
Protein labeling was performed using Immunoprobe Bio-
tinylation Kit following the manufacturer’s instructions.
Briefly, the content of one vial of biotinamidohexanoic
acid 3-sulfo-N-hydroxysuccinimide ester (BAC-Sulfo NHS)
was dissolved with 30 mL of DMSO, then 0.1M sodium
phosphate buffer (pH Z 7.2) was added to prepare a final
volume of 0.5 mL. The resulting concentration of the BAC-
Sulfo NHS solution was 10 mg/mL. Immediately, 38 mL of
the BAC-Sulfo NHS solution was added to 1.0 mL of the
antibody solution and incubated with gentle stirring for 30
minutes at room temperature (RT). Then the reacting
mixture was applied to the gel filtration column to isolate
the labeled antibody and 0.5 mL fractions were collected.
The highest protein concentration was found in Fraction 4
by measuring absorbance at 280 nm. The test was devised
in three formats: capture ELISA, microfuge tube assay,
and cartridge assay.
Capture ELISA for BCG
Various concentrations of BCG were diluted in a volume of
300 mL PBS containing 2 mg/mL BSA and 0.01% Tween-20.
The microfuge tubes containing diluted BCG were prepared
in three series. One series was pre-incubated with 1 mg/mL
(1:20), the second series with a dilution of 1/100 bio-
tinylated antibody, and the third series with BCG only. Pre-
incubation was at 37C for 1 hour with gentle stirring. The
tubes were then subjected to three washes. To wash the
contents of the tubes, they were centrifuged at 10,000  g
for 3 minutes, the supernatant was discarded, and the
pellet was resuspended in the same buffer.
The ELISA plates were coated with 10 mg/mL STA in ac-
etate buffer (0.01M, pH 5.5) overnight at 4C. The plates
were blocked with 1% BSA in PBS for 1 hour at RT, and then
washed three times with washing solution. The contents of
the tubes were applied to the ELISA plates, and incubated
for 50 minutes at RT. Five washes were carried out on the
plates and then they were incubated with STAeALP in
50 mM Tris buffer, pH 7.5 for 20 minutes at RT. Finally, the
plates were washed four times with 0.1% Tween-20 solutionSciences from ClinicalKey.com by Elsevier on June 18, 2019.
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p-Nitrophenyl Phosphate (pNPP) substrate in 50 mM Dieth-
anolamin (DEA) buffer containing 1 mM MgCl2 was added to
each well and left at RT for 30 minutes.
Capture ELISA for MTB
The MTB bacilli were obtained from clinical isolates and
inactivated in a water bath at 80C for 20minutes. According
to our institutional ethical board, informed consent was not
necessary because samples were already collected for other
purposes. Two concentrations of bacilli (1.5 104 bacilli/mL
and 1.5  105 bacilli/mL) were diluted in a volume of 300 mL
PBS containing 2 mg/mL BSA and 0.01% Tween-20. These di-
lutions were then pre-incubated with a 1:50 dilution of bio-
tinylated antibody in the medium at 37C for 1 hour with
gentle stirring. Tubes were subjected to three subsequent
washes. To wash the contents of the tubes, they were
centrifuged at 10,000 g for 5minutes, the supernatant was
discarded, and the pellet was re-suspended in the same
buffer. The following steps were conducted exactly as was
described for the capture ELISA for BCG.
Microfuge tube assay
Various concentrations of BCG were diluted in a volume of
500 mL PBS containing 2 mg/mL BSA and 1% Tween-20. The
tubes containing diluted BCG were pre-incubated with 1:50
biotinylated antibody at 37C for 1 hour with gentle stir-
ring. Tubes were subjected to three washes. To wash the
tubes, they were centrifuged at 10,000  g for 3 minutes,
the supernatant was discarded, and the pellet was sus-
pended in 50 mM Tris buffer containing 2 mg/mL BSA and
0.01% Tween-20. After the last wash, the pellet was sus-
pended in 100 mL of the STAeALP conjugate at RT for 20
minutes. Following three more washes using 0.1% Tween-20
solution, tubes were incubated with 200 mL pNPP and the
optical density (OD) was measured after 30 minutes.
Cartridge assay
The pre-incubation steps were similar to that of the
microfuge tube assay. The contents of the pre-incubated
tubes with biotinylated antibody were applied to the car-
tridges, and then there were three washes using 1% Tween-
20 solution. In this step, unbound antibodies and other
small molecules were filtrated through the cartridge filter,
and only the antibodies bound to the bacilli were retained
by the filter. The STAeALP conjugate (100 mL) was then
added to the cartridge filter, and after three washes 200 mL
of pNPP was added. Finally, photography was carried out
after 10 minutes. Fig. 1 depicts the steps involved in the
experiments.
Results
Capture ELISA for BCG
Using the newly established capture ELISA, we determined
ODs at lower concentrations of BCG compared with the ZNDownloaded for Anonymous User (n/a) at Iran University of Medic
For personal use only. No other uses without permissionstaining method (Fig. 2). The sensitivity of the capture
ELISA was 100-fold higher than ZN direct microscopy
considering the lower detection limit of 15,000 bacilli/mL
in ZN staining and 150 bacilli/mL in ELISA. According to the
figure, using a lower dilution (higher concentration) of
biotinylated antibody resulted in higher ODs with the same
BCG concentrations. To ensure that ODs were not due to
nonspecific bindings of antibody molecules to the ELISA
plates, we measured the absorbance of the antibody
without BCG and BCG without antibody and found these to
be insignificant.
Capture ELISA for MTB
Using the newly established capture ELISA, we compared
ODs at two concentrations of MTB. At the lowest concen-
tration, we detected the lowest detection limit of MTB with
the ZN staining method (1.5  104 bacilli/mL; Fig. 3).
Microfuge tube assay
Using the microfuge tube assay, we measured the ODs of
very low BCG concentrations that did not stain positive with
the ZN method (Fig. 4). Owing to the novel microfuge tube
assay, it was possible to detect BCG concentrations as little
as 1000 bacilli/mL approximately.
Cartridge assay
Fig. 5 shows the response of serially diluted BCG
(0e1.5  105 bacilli/mL). The yellow color represents a
positive reaction. Based on the figure, using lower antibody
dilutions (1:20) resulted in positive reactions at lower BCG
concentrations, i.e., 1.5  104 bacilli/mL with 1:20 anti-
body compared to 1.5  105 bacilli/mL with 1:100 antibody.
However, with the naked eye we observed a weak positive
reaction at a BCG concentration of 7.5  103 bacilli/mL
using 1:20 antibody, which is not easily visible in the
photograph.
Fig. 6 shows a comparison of the lower detection limits
of the three test formats.
Discussion
TB is a crucial health problem and controlling the disease
requires rapid and accurate diagnosis. However, ZN direct
microscopy as the most common rapid test used in
resource-poor countries where TB has the highest incidence
is not sufficiently sensitive and specific.2
The methods proposed here are both patient and
technician friendly. Only one sputum sample is required at
the first visit and a large number of specimens can be
handled simultaneously. Additionally, expensive equip-
ment and materials are not required to perform these
rapid tests. Although the new assay may seem more
expensive than direct microscopy at a glance, we believe
it is more cost-effective than the conventional direct
microscopy method considering the cost of repetitive
sampling and culturing sputum for negative cases. A cost-
effective study is needed to explore our idea.10al Sciences from ClinicalKey.com by Elsevier on June 18, 2019.
. Copyright ©2019. Elsevier Inc. All rights reserved.
Figure 1. Illustrated scheme of the three assay formats. Each assay format has three steps. Step 1 represents pre-incubated
bacilli (or BCG) with biotinylated antibody. The biotin molecules are not shown in the microfuge tube assay and the cartridge
assay. Step 2 represents the addition of the STAeALP conjugate. Step 3 represents addition of the substrate. BCG Z Bacillus
Calmette-Gue´rin; STAeALP Z streptavidinealkaline phosphatase.
100 S. Hamzehlou, M.M. FarajollahiChemically, the assay is based on pre-incubation of bio-
tinylated rabbit antibody against A60 with a sample con-
taining BCG or MTB followed by incubation with a
STAeALP conjugate. In all immunochemical assays, cap-
ture of analytes using antibodies requires long incubation
to obtain a good response; however, this is not always
feasible due to high nonspecific binding of antibody to the
solid support in ELISA formats. In the present work, we
circumvented this problem through the pre-incubation
approach in a tube, prior to adding to the ELISA wells.11
The second step of the assay took advantage of rapid
capture of the biotinylated antibody with an STA enzyme
conjugate with a very high affinity (Kd Z 10
15). To our
knowledge, such use of biotineavidin chemistry to detect
microbial cells is novel and it may be employed to detect
other pathogens in clinical specimens or microbial
cultures.
Although there are more sensitive antigens for serodi-
agnosis of TB,12e15 we simply wanted to display the feasi-
bility of the technique; we have probably not selected theDownloaded for Anonymous User (n/a) at Iran University of Medical 
For personal use only. No other uses without permission. Cbest antigen for TB serodiagnosis, and this was due to the
unavailability of other antibodies.
Such use of the biotineavidin system improved the lower
detection limit 100-fold in the capture ELISA for BCG as
illustrated in Fig. 2. The higher sensitivity compared to
direct microscopy was due to the highly specific in-
teractions of avidinebiotin molecules. Moreover, because
more than one A60 exists on a single bacterium (Fig. 1),
more than one biotinylated antibody binds to the antigen
resulting in signal amplification. Furthermore, we circum-
vented the problem of low signal-to-noise ratio owing to
the pre-incubation method. To ensure that the resulting
response was not due to nonspecific bindings of the anti-
body molecules to the ELISA plates, we measured the OD of
the antibody without BCG and BCG without antibody and
found these to be unnoticeable.
In the capture ELISA for MTB, we determined a lower
detection limit of 1.5  104 bacilli/mL similar to ZN direct
microscopy. Although there was no improvement compared
to the ZN method, we wanted to show that the test was alsoSciences from ClinicalKey.com by Elsevier on June 18, 2019.
opyright ©2019. Elsevier Inc. All rights reserved.
Figure 2. The results of the capture assay using BCG as the
analyte. The ODs of various concentrations of BCG (bacilli/mL)
after performing the test with two different dilutions of bio-
tinylated rabbit antibody. The ZN staining result for each BCG
concentration is shown on the graph. BCGZ Bacillus Calmette-
Gue´rin; Bio-Rab Ab Z biotinylated rabbit polyclonal antibody;
OD Z optical density; ZN Z Ziehl-Neelsen.
Direct detection of Mycobacterium in solution 101applicable for MTB. Such lack of improvement is probably
because A60 does not expose in MTB in a way that it does in
BCG. Furthermore, there is evidence that A60 proportions
vary depending on the growth stage of the bacteria. A60
from BCG contains equal amounts of protein, lipids, and
carbohydrates during the stationary phase of growth, but
the protein content can increase to be seven times higher
than that of polysaccharides in the exponential phase of
growth.16 Similarly, this could be true of MTB resulting in
incongruity between the results obtained from BCG and
MTB assays. We believe that the method will be more
suitable for MTB detection if antibodies against moreFigure 3. The results of the capture assay using bacilli as
analytes. The ODs of two MTB concentrations are displayed.
The OD of bacilli without antibody and the OD of antibody
alone are shown. MTB Z Mycobacterium tuberculosis;
OD Z optical density.
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Early Secreted Antigen Target-6 ESAT-612e15 are used.
The capture ELISA format showed a very high sensitivity
detecting as little as 150 bacilli/mL of BCG. The microfuge
format showed a moderately high sensitivity detecting
approximately 1000 bacilli/mL of BCG. Finally, the car-
tridge assay showed an acceptable sensitivity detecting
7.5  103 bacilli/mL of BCG. In other words, the ELISA
format, the microfuge format, and the cartridge assay
resulted in 100-, 16-, and 2-fold improvement, respectively,
in the lower detection limit of BCG when compared with
direct microscopy (i.e., 1.5  104 bacilli/mL of BCG)
(Fig. 6).
Additionally, the microfuge tube format did not
require ELISA plates and an ELISA reader to perform the
test. Moreover, because the cartridge assay did not
require extensive equipment and expertise to carry out, it
can be considered as a point-of-care test (POCT). If the
cartridge assay is done using monoclonal antibodies
rather than polyclonal ones, it may lead to a lower
detection limit.
All three assay formats were practically faster and
more sensitive than ZN direct microscopy. For high quality
smear examination, the technical guide of the Interna-
tional Union against Tuberculosis recommends that each
laboratory technician should not process and read more
than 25 ZN-stained sputum specimens per day, and that no
more than 10e12 specimens should be processed at one
time. The guide recommends that technicians should take
at least 5 minutes to examine a slide. Therefore, consid-
ering these recommendations and an average 15-minute
time for smear preparation, every 12 specimens takes
around 1 hour and 15 minutes to be processed and
examined thoroughly, taking about 3 hours per day per
technician for 25 specimens. On comparison, the ELISA,Figure 4. The results of the microfuge tube assay using BCG
as analyte. The ODs of various concentrations of BCG (bacilli/
mL) detected with biotinylated rabbit antibody. The ZN
staining result for each BCG concentration is shown on the
graph. BCG Z Bacillus Calmette-Gue´rin; Bio-Rab
Ab Z biotinylated rabbit polyclonal antibody; OD Z optical
density; ZN Z Ziehl-Neelsen.
al Sciences from ClinicalKey.com by Elsevier on June 18, 2019.
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Figure 5. The results of the cartridge assay at different BCG and antibody concentrations. The numbers 0, 1, 2, 3, 4, and 5
represent 0 bacilli/mL, 7,500 bacilli/mL, 15,000 bacilli/mL, 30,000 bacilli/mL, 60,000 bacilli/mL, and 120,000 bacilli/mL of BCG.
The test was done with 1:100 antibody dilution (upper row) and 1:20 antibody dilution (lower row). BCG Z Bacillus Calmette-
Gue´rin.
Figure 6. Comparison of the lower limit of detection of the
three test formats with the ZN direct microscopy method.
BCG Z Bacillus Calmette-Gue´rin; ELISA Z enzyme-linked
immunosorbent assay; ZN Z Ziehl-Neelsen.
102 S. Hamzehlou, M.M. Farajollahimicrofuge, and cartridge assay proposed here takes about
2 hours to be completed thoroughly, and the method could
be applied to 96-well ELISA plate and no less than 25
specimens simultaneously (compared to 25 ZN-stained
specimens).
In conclusion, our results are very promising in terms of
improving sensitivity and cost for detection of various
Mycobacterium species. The assay needs further evaluation
using antibodies against specific antigens for direct diag-
nosis of MTB and also other pathogens in clinical samples.Conflicts of interest
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